XCLINICAL GMBH, Munich, Germany – May 14, 2008 – XClinical, a European vendor of innovative software products for eClinical trials, announced the use of MARVIN, its CDISC ODM certified EDC solution, in a large European multicentric clinical trial conducted by its Munich-based customer, OSE Oncology Services Europe S.a.r.l. (OSE).
The study, initiated by the subsidiary of a global pharmaceutical company, will take place in 20 countries and involves up to 160 sites. OSE, who has only recently joined XClinical’s growing customer list, and was trained on MARVIN in a very short time, is responsible for the project. MARVIN’s special ability to combine EDC (Electronic Data Capture) and DDE (Double Data Entry) was the key feature in being chosen for the mentioned study.
Dr. Markus Zabransky, Global Medical Manager at the Switzerland-based pharmaceutical company, was excited about XClinical’s comprehensive EDC software suite: “The presentation of MARVIN totally convinced me that our collaboration partner, OSE, has chosen the right EDC software solution for our company’s complex and critical clinical trials in biopharmaceuticals.”
“We are pleased to add one of the global players in biopharmaceutical research to our growing EDC user list,” said Olga Steinle, account manager at XClinical. “The marketplace has been embracing our approach to EDC as it provides a solution that is comfortable for sites to use and robust for data management and sponsor personnel. MARVIN is an ideal combination giving sites and sponsors what they are looking for in an EDC system.”
You must be logged in to post a comment Login